NewGenIvf Group Limited (NIVF) Revenue History
Annual and quarterly revenue from 2021 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
NIVF Revenue Growth
Revenue Breakdown
NIVF's revenue distribution by segment and geography
By Geography
NIVF Revenue Analysis (2021–2024)
As of May 8, 2026, NewGenIvf Group Limited (NIVF) generated trailing twelve-month (TTM) revenue of $2.8 million, reflecting significant decline in growth of -16.2% year-over-year. The most recent quarter (Q4 2024) recorded $1.3 million in revenue, down 16.2% sequentially.
Looking at the longer-term picture, NIVF's historical revenue data shows a 3-year CAGR of +9.7%. The company achieved its highest annual revenue of $5.9 million in 2022.
When compared to Healthcare sector peers including NTRA (+35.9% YoY), PGNY (+6.6% YoY), and TMHC (-9.0% YoY), NIVF has underperformed the peer group in terms of revenue growth. Compare NIVF vs NTRA →
NIVF Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| NIVFCurrent | $3M | -16.2% | - | -21.4% | |
 NTRA | $2.3B | +35.9% | +42.6% | -13.4% | |
 PGNY | $1.3B | +6.6% | +30.2% | 6.6% | |
 TMHC | $8.1B | -9.0% | +5.8% | 14.0% | |
 HIMS | $2.3B | +59.0% | +73.6% | 5.2% | |
 ILMN | $4.3B | +1.2% | +6.0% | 19.9% |
NIVF Historical Revenue Data (2021–2024)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $5.4M | +5.8% | $1.8M | 33.6% | $-1,160,000 | -21.4% |
| 2023 | $5.1M | -13.6% | $1.7M | 32.7% | $42K | 0.8% |
| 2022 | $5.9M | +44.3% | $1.5M | 25.9% | $-504,907 | -8.5% |
| 2021 | $4.1M | - | $1.0M | 24.9% | $199K | 4.8% |
See NIVF's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs NIVF Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare NIVF vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonNIVF — Frequently Asked Questions
Quick answers to the most common questions about buying NIVF stock.
Is NIVF's revenue growth accelerating or slowing?
NIVF revenue declined -16.2% year-over-year, contrasting with the 5-year CAGR of N/A. TTM revenue fell to $3M. This reverses the prior growth trend.
What is NIVF's long-term revenue growth rate?
NewGenIvf Group Limited's 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of -16.2% is below this long-term average.
How is NIVF's revenue distributed by segment?
NIVF reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2021-2024 are available for download. Segment mix reveals concentration and diversification trends.